Table 3.
Characteristic | Number (%) |
---|---|
Patient numbers | |
Total number patients entered | 46 |
Number undergoing surgery | 44 (100%)(a) |
Number tumor resected | 42 (91%) (b) |
Age surgery (yrs) | |
Mean ± SEM | 49 ± 2 |
[range] | [27.5-81) |
Duration diagnosis to surgery (yrs) | |
Mean ± SEM | 5.3 ± 1.1 |
[range] | [0.1-18.8] |
Primary PET location/size (surgery) | |
Location | |
Pancreas | 30 (68%) |
Duodenum | 12 (27%) |
Other | 5 (11%)(c) |
Largest Primary size (cm) | |
Mean ± SEM | 5 ± 0.6 |
[range] | [0.4-15] |
Metastases found at surgery | |
Lymph node involvement | 31 (70%) |
Liver metastases | 18 (41%)(d) |
Tumor extent at surgery | |
Primary only | 8 (18%) |
Primary plus lymph node involvement | 31 (70%) |
With liver involvement | 20 (48%)(d) |
Invasion/encasement of major vessel | 15 (36%)(e) |
Two patients refused surgery.
Two patients with gastrinomas had unresectable disease. One with diffuse peritoneal implants/diffuse small liver metastases and the second with complete encasement of the IVC/portal vein with arterial invasion with bleeding. The number of patients undergoing surgery was used as 100% in this table.
Other refers to 1 patient with a primary gastrinoma in the bile duct (n=1), liver (n=2), heart (n=1) and lymph node (n=1).
Two patients had primary gastrinoma of the liver.
One patient had invasion of the heart by a gastrinoma, twelve encasement of the SMV or PV, one SMA and one involvement of the IVC.